The board of directors approved the company's 2021 consolidated financial report.
· Issued by Adimmune Corporation
Close
Today's Information
Provided by: ADIMMUNE CORPORATION
SEQ_NO
4
Date of announcement
2022/03/29
Time of announcement
13:46:25
Subject
The board of directors approved the company's
2021 consolidated financial report.
Date of events
2022/03/29
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/29
2.Date of approval by the audit committee:2022/03/25
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):1641061
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):464145
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):-206806
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):14285
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):14285
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):43066
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.10
11.Total assets end of the period (thousand NTD):8010087
12.Total liabilities end of the period
(thousand NTD):1577545
13.Equity attributable to owners of parent end of the
period (thousand NTD):6148822
14.Any other matters that need to be specified:NA
